Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:30 PM
Ignite Modification Date:
2025-12-24 @ 4:30 PM
NCT ID:
NCT06151366
Eligibility Criteria:
Inclusion Criteria:
* Under the care of the Lung Defence Clinic at Royal Papworth Hospital
* CT confirmed diagnosis of bronchiectasis
* Age \>/= 18 years
* Had two or more clinician defined APEs in the year prior to enrolment
* Typically expectorates sputum daily
* Considered suitable for home monitoring in the opinion of the investigator
* Able to provide written informed consent
Exclusion Criteria:
* Patients unable to provide written informed consent
* Known cystic fibrosis
* Lung transplant recipients or on lung transplant waiting list
* Use of long-term oxygen therapy (LTOT) or non-invasive ventilation to manage respiratory failure
* Patients unwilling to consent to their link anonymised data from home monitoring being used for research
* Patients unable to use a smartphone. Patients who would like to take part but do not have a smartphone can be provided with one.
* Patients who do not have reliable Wi-Fi at home or are unable to access public Wi-Fi at least twice per week.
* Considered unsuitable for home monitoring in the opinion of the investigator
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
100 Years
Study:
NCT06151366
Study Brief:
Protocol Section:
NCT06151366